TTK Healthcare last traded at ₹1,021.90 (2026-10-13). Over the past month the stock moved -9.9%, three months the stock moved +11.7%, year the stock moved -13.8%. Its closing range over 52 weeks is ₹761.85 – ₹1,195.00, with the latest close 14.5% below the high.
Closing prices up to 2026-10-13.
TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1] It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]
Business Segments 1. Consumer Products : The company markets and distributes products that transcend categories; baby care (Woodward’s Gripe Water), personal care (Eva Deodrants), home care- room & air fresheners (Good Home ), and sexual wellness (Skore). [1] The Woodward's Gripe Water is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. It has a distribution network of 27 warehouses, 2,600+ distributors, 650+ frontline sales teams, and a reach of ~4 lakh outlets across India. [2]
In the latest quarter (Jun 2026), TTK Healthcare reported sales of ₹258.00 crore (+14.2%) and net profit of ₹21.00 crore (+61.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 258.00 | 15.00 | 6.00 | 21.00 | 15.06 |
| Mar 2026 | 218.00 | 11.00 | 5.00 | 22.00 | 15.40 |
| Dec 2025 | 209.00 | 7.00 | 3.40 | 11.00 | 7.45 |
| Sep 2025 | 204.00 | 5.00 | 2.60 | 20.00 | 14.43 |
| Jun 2025 | 226.00 | 3.00 | 1.20 | 13.00 | 9.20 |
| Mar 2025 | 190.00 | 12.00 | 6.00 | 16.00 | 11.43 |
| Dec 2024 | 205.00 | 8.00 | 3.80 | 17.00 | 11.84 |
| Sep 2024 | 198.00 | 8.00 | 4.20 | 17.00 | 12.17 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +6.5% | +11.4% | +5.0% | +8.7% | +3.0% | +2.0% | +14.7% | +14.2% |
| Operating profit growth | -20.0% | +60.0% | +0.0% | -57.1% | -37.5% | -12.5% | -8.3% | +400.0% |
| Net profit growth | +6.3% | +30.8% | -11.1% | -59.4% | +17.6% | -35.3% | +37.5% | +61.5% |
| EPS growth | +7.4% | +29.8% | -11.6% | -58.8% | +18.6% | -37.1% | +34.7% | +63.7% |
| OPM % | 4.2% | 3.8% | 6.0% | 1.2% | 2.6% | 3.4% | 5.0% | 6.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), TTK Healthcare reported sales of ₹857.00 crore (+7.0%) and net profit of ₹66.00 crore (-19.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 857.00 | 26.00 | 3.00 | 66.00 | 46.48 |
| Mar 2025 | 801.00 | 35.00 | 4.00 | 82.00 | 57.79 |
| Mar 2024 | 753.00 | 37.00 | 5.00 | 63.00 | 44.47 |
| Mar 2023 | 725.00 | 31.00 | 4.00 | 640.00 | 452.72 |
| Mar 2022 | 599.00 | 22.00 | 4.00 | 42.00 | 29.43 |
| Mar 2021 | 476.00 | 19.00 | 4.00 | 46.00 | 32.87 |
| Mar 2020 | 646.00 | 28.00 | 4.00 | 12.00 | 8.72 |
| Mar 2019 | 628.00 | 50.00 | 8.00 | 24.00 | 17.25 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +8.7% | +2.9% | -26.3% | +25.8% | +21.0% | +3.9% | +6.4% | +7.0% |
| Operating profit growth | +16.3% | -44.0% | -32.1% | +15.8% | +40.9% | +19.4% | -5.4% | -25.7% |
| Net profit growth | +33.3% | -50.0% | +283.3% | -8.7% | +1423.8% | -90.2% | +30.2% | -19.5% |
| EPS growth | +34.1% | -49.4% | +276.9% | -10.5% | +1438.3% | -90.2% | +30.0% | -19.6% |
| OPM % | 8.0% | 4.0% | 4.0% | 4.0% | 4.0% | 5.0% | 4.0% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for TTK Healthcare.
Get Free AI Stock Analysis FREE →TTK Healthcare to sell EVA and Good Home brands for ₹256 crore - scanx.trade
TTK Healthcare shares were last quoted at ₹1,021.90 (+0.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
TTK Healthcare has a price-to-earnings (P/E) ratio of 19.75 and a price-to-book (P/B) ratio of 1.29. The industry P/E is 53.33.
The 52-week high of TTK Healthcare is ₹1,250.00 and the 52-week low is ₹737.00.
The market capitalisation of TTK Healthcare is about ₹1,460.65 crore.
In the latest quarter (Jun 2026), TTK Healthcare reported sales of ₹258.00 crore (+14.2%) and net profit of ₹21.00 crore (+61.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, TTK Healthcare has a 3-year ROE of 7.00%, 3-year profit growth of -52.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 74.56% of TTK Healthcare.
TTK Healthcare belongs to the Pharmaceuticals & Drugs sector.